Clopidogrel vs Ticagrelor or Prasugrel After Primary PCI According to CYP2C19 Genotype
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Circulation: Cardiovascular Interventions
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Clopidogrel Versus Ticagrelor or Prasugrel After Primary Percutaneous Coronary Intervention According to CYP2C19 Genotype: A POPular Genetics Subanalysis
Circ Cardiovasc Interv 2021 Mar 16;[EPub Ahead of Print], DMF Claassens, TO Bergmeijer, GJA Vos, RS Hermanides, AWJ van 't Hof, P van der Harst, E Barbato, C Morisco, RM Tjon Joe Gin, FW Asselbergs, A Mosterd, JR Herrman, WJM Dewilde, PWA Janssen, JC Kelder, BK Mahmoodi, VHM Deneer, JM Ten BergFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.